Literature DB >> 16288034

Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2.

Mark C Wilkes1, Hugh Mitchell, Sumedha Gulati Penheiter, Jules J Doré, Kaori Suzuki, Maryanne Edens, Deepak K Sharma, Richard E Pagano, Edward B Leof.   

Abstract

Transforming growth factor-beta (TGF-beta) stimulates cellular proliferation and transformation to a myofibroblast phenotype in vivo and in a subset of fibroblast cell lines. As the Smad pathway is activated by TGF-beta in essentially all cell types, it is unlikely to be the sole mediator of cell type-specific outcomes to TGF-beta stimulation. In the current study, we determined that TGF-beta receptor signaling activates phosphatidylinositol 3-kinase (PI3K) in several fibroblast but not epithelial cultures independently of Smad2 and Smad3. PI3K activation occurs in the presence of dominant-negative dynamin and is required for p21-activated kinase-2 kinase activity and the increased proliferation and morphologic change induced by TGF-beta in vitro.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288034     DOI: 10.1158/0008-5472.CAN-05-1522

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  89 in total

1.  Interrelationship between protein phosphatase 1 and TGF-{beta} in regulating motility and cytoskeletal architecture of endothelial cells.

Authors:  Jarrett E Walsh; M Rita I Young
Journal:  Anticancer Res       Date:  2010-12       Impact factor: 2.480

2.  Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts.

Authors:  Jeffrey C Horowitz; David S Rogers; Vishal Sharma; Ragini Vittal; Eric S White; Zongbin Cui; Victor J Thannickal
Journal:  Cell Signal       Date:  2006-11-17       Impact factor: 4.315

3.  Phosphatidylinositol 3-kinase/Akt pathway targets acetylation of Smad3 through Smad3/CREB-binding protein interaction: contribution to transforming growth factor beta1-induced Epstein-Barr virus reactivation.

Authors:  Lassad Oussaief; Aurélie Hippocrate; Vanessa Ramirez; Aurore Rampanou; Wei Zhang; David Meyers; Philip Cole; Ridha Khelifa; Irène Joab
Journal:  J Biol Chem       Date:  2009-07-09       Impact factor: 5.157

4.  Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.

Authors:  Tawin Iempridee; Shreyasi Das; Iris Xu; Janet E Mertz
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

Review 5.  Single Nucleotide Polymorphism in SMAD7 and CHI3L1 and Colorectal Cancer Risk.

Authors:  Amal Ahmed Abd El-Fattah; Nermin Abdel Hamid Sadik; Olfat Gamil Shaker; Amal Mohamed Kamal
Journal:  Mediators Inflamm       Date:  2018-10-25       Impact factor: 4.711

Review 6.  Regulation and Role of TGFβ Signaling Pathway in Aging and Osteoarthritis Joints.

Authors:  Catherine Baugé; Nicolas Girard; Eva Lhuissier; Celine Bazille; Karim Boumediene
Journal:  Aging Dis       Date:  2013-12-17       Impact factor: 6.745

Review 7.  The TGFBeta pathway as a therapeutic target in cancer.

Authors:  J Seoane
Journal:  Clin Transl Oncol       Date:  2008-01       Impact factor: 3.405

8.  Specific activation of mitogen-activated protein kinase by transforming growth factor-beta receptors in lipid rafts is required for epithelial cell plasticity.

Authors:  Wei Zuo; Ye-Guang Chen
Journal:  Mol Biol Cell       Date:  2008-12-03       Impact factor: 4.138

9.  Type II transforming growth factor-beta receptor recycling is dependent upon the clathrin adaptor protein Dab2.

Authors:  Sumedha G Penheiter; Raman Deep Singh; Claire E Repellin; Mark C Wilkes; Maryanne Edens; Philip H Howe; Richard E Pagano; Edward B Leof
Journal:  Mol Biol Cell       Date:  2010-09-29       Impact factor: 4.138

10.  Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta.

Authors:  Mark C Wilkes; Claire E Repellin; Min Hong; Margarita Bracamonte; Sumedha G Penheiter; Jean-Paul Borg; Edward B Leof
Journal:  Dev Cell       Date:  2009-03       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.